Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 7861 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

IBA Notice of Full Year 2023 Results and Conference Call

Read more ››
By: GlobeNewswire - 26 Feb 2024
Related companies:  Ion Beam Applications S.A. (IBA)

Operation Smile and Beast Philanthropy Spotlight Global Need for Access to Surgical Care

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

Laplace Interventional Inc. Announces Successful First in Human Procedure in Early Feasibility Study of its Transcatheter Tricuspid Valve Replacement Device

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  Laplace Interventional, Inc.

Armonica Technologies announces Emily Milsovic joins Board of Directors

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  Armonica Technologies, Inc. | Armonica Technologies, Inc.

Siriraj Hospital Expands Services to Provide Advanced Medical Care, Highlights State-of-the-Art Technology for Cancer Treatment

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

Cure Brain Cancer Foundation CEO Lance Kawaguchi Completes SouthPoleTrek4Cancer, Raises Over $1 Million for Cancer Research

Read more ››
By: PR Newswire Association LLC. - 25 Feb 2024
Related companies:  Cure Brain Cancer Foundation

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies

Read more ››
By: GlobeNewswire - 25 Feb 2024
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche Ltd | Hoffmann-La Roche Ltd. (Edmonton)

Operation Smile and Beast Philanthropy Spotlight Global Need for Access to Surgical Care

Read more ››
By: PR Newswire Association LLC. - 25 Feb 2024

Groundbreaking! Phase II Data of LP-003 Unveiled by Longbio Pharma at AAAAI2024

Read more ››
By: PR Newswire Association LLC. - 25 Feb 2024

Omalizumab Increases the Reaction Threshold for Peanut and Other Common Food Allergies

Read more ››
By: PR Newswire Association LLC. - 25 Feb 2024

New England Journal of Medicine publishes Phase III data showing Xolair® (omalizumab) significantly reduced allergic reactions across multiple foods in people with food allergies

Read more ››
By: PR Newswire Association LLC. - 25 Feb 2024

Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria

Read more ››
By: GlobeNewswire - 24 Feb 2024
Related companies:  Sanofi SA

Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria

Read more ››
By: GlobeNewswire - 24 Feb 2024
Related companies:  Celldex Therapeutics, Inc.

China Medical University Hospital's Breakthrough: Leg Salvage Against Deadly Arterial Disease. Amputation and Death Rates Plunge from 30% to Below 3%

Read more ››
By: PR Newswire Association LLC. - 24 Feb 2024
Related companies:  China-Japan Friendship Hospital | Clinical Trial Center, China Medical University Hospital

Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®

Read more ››
By: GlobeNewswire - 24 Feb 2024
Related companies:  Alvotech

Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®

Read more ››
By: GlobeNewswire - 24 Feb 2024
Related companies:  Alvotech

Easterseals South Florida announces the appointment of Matthew Roth as Board Chair

Read more ››
By: PR Newswire Association LLC. - 24 Feb 2024

AMYLYX PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. - AMLX

Read more ››
By: PR Newswire Association LLC. - 24 Feb 2024
Related companies:  Amylyx Pharmaceuticals, Inc.

APhA Statement on Change Healthcare Cyberattack

Read more ››
By: PR Newswire Association LLC. - 24 Feb 2024

The Howard and Georgeanna Jones Foundation for Reproductive Medicine supports Alabama infertility patients

Read more ››
By: PR Newswire Association LLC. - 24 Feb 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑